Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 3418 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 6728 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 12371 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 12696 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 13518 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 14194 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 14470 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 15075 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 19753 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 20872 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 21789 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 25368 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 27205 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | CYSTATHIONINE (M+H)+ | 27815 | Peak area normalized | male | diabetic | no neuropathy |